Skip to main content

and
  1. Article

    Open Access

    Associations of plasma proteomics and age-related outcomes with brain age in a diverse cohort

    Machine learning models are increasingly being used to estimate “brain age” from neuroimaging data. The gap between chronological age and the estimated brain age gap (BAG) is potentially a measure of accelerat...

    Ramon Casanova, Keenan A. Walker, Jamie N. Justice, Andrea Anderson in GeroScience (2024)

  2. No Access

    Article

    Mid-life plasma proteins associated with late-life prefrailty and frailty: a proteomic analysis

    Physical frailty is a syndrome that typically manifests in later life, although the pathogenic process causing physical frailty likely begins decades earlier. To date, few studies have examined the biological ...

    Fangyu Liu, Jennifer A. Schrack, Jeremy Walston, Rasika A. Mathias in GeroScience (2024)

  3. No Access

    Article

    Severe infections as a gateway to dementia

    A study in Nature Aging on electronic health records from 1.7 million people in New Zealand reveals that most patients with dementia have a history of hospital-treated infection. In a dementia-free population, in...

    Mika Kivimäki, Keenan A. Walker in Nature Aging (2024)

  4. Article

    Open Access

    Proteomic analysis of cardiorespiratory fitness for prediction of mortality and multisystem disease risks

    Despite the wide effects of cardiorespiratory fitness (CRF) on metabolic, cardiovascular, pulmonary and neurological health, challenges in the feasibility and reproducibility of CRF measurements have impeded i...

    Andrew S. Perry, Eric Farber-Eger, Tomas Gonzales, Toshiko Tanaka in Nature Medicine (2024)

  5. Article

    Open Access

    Association between retinal microvascular abnormalities and late-life brain amyloid-β deposition: the ARIC-PET study

    Retinal microvascular signs are accessible measures of early alterations in microvascular dysregulation and have been associated with dementia; it is unclear if they are associated with AD (Alzheimer’s disease...

    Marco Egle, Jennifer A. Deal, Keenan A. Walker in Alzheimer's Research & Therapy (2024)

  6. Article

    Open Access

    Alzheimer’s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline

    Although blood-based biomarkers have been identified as cost-effective and scalable alternatives to PET and CSF markers of neurodegenerative disease, little is known about how these biomarkers predict future b...

    Heather E. Dark, Yang An, Michael R. Duggan in Alzheimer's Research & Therapy (2024)

  7. Article

    Open Access

    Associations between genetically predicted plasma protein levels and Alzheimer’s disease risk: a study using genetic prediction models

    Specific peripheral proteins have been implicated to play an important role in the development of Alzheimer’s disease (AD). However, the roles of additional novel protein biomarkers in AD etiology remains elus...

    **g**g Zhu, Shuai Liu, Keenan A. Walker, Hua Zhong in Alzheimer's Research & Therapy (2024)

  8. Article

    Open Access

    Identification of circulating proteins associated with general cognitive function among middle-aged and older adults

    Identifying circulating proteins associated with cognitive function may point to biomarkers and molecular process of cognitive impairment. Few studies have investigated the association between circulating prot...

    Adrienne Tin, Alison E. Fohner, Qiong Yang, Jennifer A. Brody in Communications Biology (2023)

  9. Article

    Open Access

    The role of peripheral inflammatory insults in Alzheimer’s disease: a review and research roadmap

    Peripheral inflammation, defined as inflammation that occurs outside the central nervous system, is an age-related phenomenon that has been identified as a risk factor for Alzheimer’s disease. While the role o...

    Keenan A. Walker, Lydia M. Le Page, Niccolò Terrando in Molecular Neurodegeneration (2023)

  10. Article

    Open Access

    Correction to: Plasma proteins related to inflammatory diet predict future cognitive impairment

    Michael R. Duggan, Lauren Butler, Zhongsheng Peng, Gulzar N. Daya in Molecular Psychiatry (2023)

  11. Article

    Open Access

    Plasma proteins related to inflammatory diet predict future cognitive impairment

    Dysregulation of the immune system and dietary patterns that increase inflammation can increase the risk for cognitive decline, but the mechanisms by which inflammatory nutritional habits may affect the develo...

    Michael R. Duggan, Lauren Butler, Zhongsheng Peng, Gulzar N. Daya in Molecular Psychiatry (2023)

  12. No Access

    Article

    New IDEAS about amyloid, race and dementia disparities

    In a study of 17,000 Medicare beneficiaries with mild cognitive impairment or dementia, non-Hispanic white older adults were more likely than Asian, Black or Hispanic older adults to have elevated cortical amy...

    Heather E. Dark, Keenan A. Walker in Nature Reviews Neurology (2023)

  13. Article

    Open Access

    Assessment of variability in the plasma 7k SomaScan proteomics assay

    SomaScan is a high-throughput, aptamer-based proteomics assay designed for the simultaneous measurement of thousands of proteins with a broad range of endogenous concentrations. In its most current version, th...

    Julián Candia, Gulzar N. Daya, Toshiko Tanaka, Luigi Ferrucci in Scientific Reports (2022)

  14. No Access

    Article

    Reducing decoys focuses fighting microglia

    Genetic variation linked to lower levels of soluble ST2, a decoy cytokine receptor for IL-33, may protect against Alzheimer’s disease in women carrying the APOEε4 allele by increasing microglial plaque removal. T...

    Michael R. Duggan, Keenan A. Walker in Nature Aging (2022)

  15. No Access

    Article

    The Role of Chronic Infection in Alzheimer’s Disease: Instigators, Co-conspirators, or Bystanders?

    Herein, we provide a critical review of the clinical and translational research examining the relationship between viral and bacterial pathogens and Alzheimer’s disease. In addition, we provide an overview of ...

    Lauren Butler, Keenan A. Walker in Current Clinical Microbiology Reports (2021)

  16. No Access

    Article

    Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk

    The plasma proteomic changes that precede the onset of dementia could yield insights into disease biology and highlight new biomarkers and avenues for intervention. We quantified 4,877 plasma proteins in nonde...

    Keenan A. Walker, **gsha Chen, **gning Zhang, Myriam Fornage, Yunju Yang in Nature Aging (2021)

  17. No Access

    Article

    Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review

    Hypertension is a highly prevalent condition which has been established as a risk factor for cardiovascular and cerebrovascular disease. Although the understanding of the relationship between cardiocirculatory...

    Keenan A. Walker, Melinda C. Power, Rebecca F. Gottesman in Current Hypertension Reports (2017)